Published 2 days ago • loading... • Updated 2 days ago
Multi-Stakeholder Expert Panel Finds UTI Management in the United States Represents a Solvable Systemic Failure Costing More Than $6 Billion Annually
The paper says outdated urine culture methods and wrong antibiotic choices drive more than $6 billion in annual U.S. costs and avoidable harm.
On Tuesday, Pathnostics published a white paper examining the systemic UTI crisis in the United States, identifying more than 13 million diagnosed cases and an estimated $6 billion in direct healthcare costs annually.
The panel identified a twofold diagnostic failure in detection and direction; standard urine culture, based on 1950s criteria, may miss up to 75% of relevant organisms and complicates effective treatment.
Escalated care—emergency visits, hospitalizations, and skilled nursing stays—accounts for 53.5% of UTI-related Medicare costs following first-line treatment failure, producing exactly the resistance its design predicts, experts say.
Glenn Werneburg, MD, PhD, warned: "Many of these patients over time are getting to the point where there are no good antibiotic choices left," citing compounding harm from initial therapeutic errors.
Melissa Kramer, PhD, emphasized: "The one true metric should be long-term patient outcomes." The white paper proposes a Why Change framework to prioritize patient results over obsolete diagnostic standards.